LNTH
Lantheus Holdings, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 129 | +5 | 56.22M | $5.58B | +13 | −7 |
| Q1 2026 | 126 | +6 | 62.19M | $3.90B | +10 | −5 |
| Q4 2025 | 120 | -2 | 60.97M | $3.47B | +2 | −3 |
| Q3 2025 | 20 | +2 | 33.16M | $1.70B | +2 | −1 |
| Q2 2025 | 16 | -2 | 29.15M | $2.39B | +1 | −3 |
| Q1 2025 | 15 | 0 | 7.80M | $761.04M | — | — |
| Q4 2024 | 15 | 0 | 6.76M | $604.90M | +2 | −2 |
| Q3 2024 | 14 | 0 | 4.84M | $531.32M | +1 | −1 |
| Q2 2024 | 14 | — | 5.72M | $459.02M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 1.65M | — | $132.58M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.65M | — | $132.58M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.24M | — | $99.61M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.24M | — | $99.61M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 746.85K | — | $59.96M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 746.85K | — | $59.96M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Norges Bank ✦ (pasivo) | 475.60K | — | $38.19M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 395.77K | — | $31.78M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 395.77K | — | $31.78M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 395.77K | — | $31.78M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 333.72K | — | $26.79M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 302.97K | — | $24.33M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 302.97K | — | $24.33M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 302.97K | — | $24.33M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 215.43K | — | $17.30M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 156.80K | — | $12.59M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 109.13K | — | $8.76M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 33.92K | — | $2.72M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 31.47K | — | $2.53M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 31.47K | — | $2.53M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 15.12K | — | $1.21M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 8.33K | — | $668,494 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 401 tenedores, 70.59M acciones, $5.23B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.